Quality of life assessment of relapsing-remitting multiple sclerosis patients on long-term treatment with Betaferon

被引:0
|
作者
Davidescu, I.
Damian, G.
机构
[1] Colentina Hosp, Dept Neurol, Bucharest, Romania
[2] UMF Carol Davila, Bucharest, Romania
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:129 / 129
页数:1
相关论文
共 50 条
  • [1] Comparison of Betaferon®, Avonex® and Rebif® in treatment of relapsing-remitting multiple sclerosis
    Shaygannejad, V.
    Etemadifar, M.
    Fereshteh, A.
    MULTIPLE SCLEROSIS, 2006, 12 : S200 - S200
  • [2] Comparison of Betaferon, Avonex, and Rebif in treatment of relapsing-remitting multiple sclerosis
    Etemadifar, M
    Janghorbani, M
    Shaygannejad, V
    ACTA NEUROLOGICA SCANDINAVICA, 2006, 113 (05): : 283 - 287
  • [3] Long-term safety and efficacy of natalizumab in relapsing-remitting multiple sclerosis: impact on quality of life
    Planas, Raquel
    Martin, Roland
    Sospedra, Mireia
    PATIENT-RELATED OUTCOME MEASURES, 2014, 5 : 25 - 33
  • [4] Improved quality of life among relapsing-remitting multiple sclerosis patients treated long-term with glatiramer acetate
    Oleen-Burkey, M.
    Johnson, K. P.
    VALUE IN HEALTH, 2008, 11 (03) : A147 - A147
  • [5] Quality of life in relapsing-remitting multiple sclerosis
    Dayapoglu, Nuray
    Tan, Mehtap
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2011, 27 (01) : 133 - 137
  • [6] Long-term outcome of minocycline in relapsing-remitting multiple sclerosis
    Zhang, Y.
    Metz, L. M.
    Yong, V. W.
    Bell, R. B.
    Yeung, M.
    Patry, D.
    Mitchel, J. R.
    MULTIPLE SCLEROSIS, 2007, 13 (09): : 1226 - 1226
  • [7] Long-term assessment of No Evidence of Disease Activity (NEDA) in patients with relapsing-remitting multiple sclerosis
    De Stefano, N.
    Stromillo, M. L.
    Giorgio, A.
    Bartolozzi, M. L.
    Battaglini, M.
    Baldini, M.
    Portaccio, E.
    Amato, M. P.
    Sormani, M. P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 26 - 26
  • [8] Radiological Evidence for the Long-Term Effect of Fingolimod Treatment in Patients with Relapsing-Remitting Multiple Sclerosis
    Cohen, Jeffrey
    Tenenbaum, Nadia
    Bhatt, Alit
    Pimentel, Ron
    Kappos, Ludwig
    NEUROLOGY, 2017, 89 (08) : E103 - E103
  • [9] Real-life long-term effectiveness of fingolimod in Swiss patients with relapsing-remitting multiple sclerosis
    Zecca, C.
    Roth, S.
    Findling, O.
    Perriard, G.
    Bachmann, V.
    Pless, M. L.
    Baumann, A.
    Kamm, C. P.
    Lalive, P. H.
    Czaplinski, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 (05) : 762 - 767
  • [10] Quality of life in 1000 patients with early relapsing-remitting multiple sclerosis
    Putzki, N.
    Fischer, J.
    Gottwald, K.
    Reifschneider, G.
    Ries, S.
    Siever, A.
    Hoffmann, F.
    Kaefferlein, W.
    Kausch, U.
    Liedtke, M.
    Kirchmeier, J.
    Gmuend, S.
    Richter, A.
    Schicklmaier, P.
    Niemczyk, G.
    Wernsdoerfer, C.
    Hartung, H. P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 (06) : 713 - 720